Publikace
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | 2. lékařská fakulta
- Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL2023 | 2. lékařská fakulta, Ústřední knihovna
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | 2. lékařská fakulta
- Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia2023 | 2. lékařská fakulta
- The KMT2A recombinome of acute leukemias in 20232023 | 2. lékařská fakulta
- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | 2. lékařská fakulta
- Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol2022 | 2. lékařská fakulta
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions2022 | 2. lékařská fakulta
- Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy2022 | 2. lékařská fakulta
- Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease2022 | 2. lékařská fakulta
Loading network view...